Interface Biologics

Interface Biologics is a commercial stage privately held company that develops transformative biomedical polymer technology to improve the safety and effectiveness of medical devices. IBI’s primary technology focus areas are anti-thrombogenic additives that reduce thrombosis in blood contacting medical devices and polymer enabled drug delivery devices.
Company Growth (employees)
Type
Private
HQ
Toronto, CA
Founded
2001
Size (employees)
25 (est)
Interface Biologics was founded in 2001 and is headquartered in Toronto, CA

Interface Biologics Office Locations

Interface Biologics has an office in Toronto
Toronto, CA (HQ)
300 101 College St

Interface Biologics Data and Metrics

Summary Metrics

Founding Date

2001

Total Funding

$32 m

Time since last funding

over 2 years

Investors

Traffic Overview of Interface Biologics

Interface Biologics Online and Social Media Presence

Interface Biologics Company Life and Culture

You may also be interested in